Stockreport

Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212 [Yahoo! Finance]

Rallybio Corporation  (RLYB) 
PDF NEW HAVEN, Conn., November 21, 2024 BUSINESS WIRE )--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into tr [Read more]